Enterococci have been recognized as important hospital-acquired pathogens in recent
years, and isolates of E. faecalis and E. faecium are the third-to fourth-most prevalent
nosocomial pathogen worldwide. Acquired resistances, especially against
penicilin/ampicillin, aminoglycosides (high-level) and glycopeptides are therapeutically
important and reported in increasing numbers. On the other hand, isolates of E. faecalis and
E. faecium are commensals of the intestines of humans, many vertebrate and invertebrate …